SCW Capital Management’s Rockwell Medical RMTI Stock Holding History

SCW Capital Management’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-831	Closed	-$252K	–	11
2019 Q3	$252K	Buy	+831	New	+$255K	0.22%	9

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SCW Capital Management's RMTI Position: Q4 2019 in Review

SCW Capital Management sold out of Rockwell Medical (RMTI) in Q4 2019, closing a stake of 831 shares — an estimated $252K sold.

SCW Capital Management first reported a position in RMTI in Q3 2019 and held it in 1 quarter. The position peaked at $252K in Q3 2019. 83 funds tracked by Wall St. Rank hold RMTI as of Q4 2019.

SCW Capital Management reported no remaining Rockwell Medical position as of Q4 2019 after selling out during the quarter.
SCW Capital Management sold 831 Rockwell Medical shares in Q4 2019, an estimated $252K.
SCW Capital Management first reported a position in Rockwell Medical in Q3 2019 and held it in 1 quarter.
SCW Capital Management's Rockwell Medical position peaked at $252K in Q3 2019.
83 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2019.

Based on SCW Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.